GlassScriptPhysician profile
Christopher R Kinter
NPI 1922118884
$17,068.12
in general payments reported to CMS, 2019-2025
9 companies · $2,882 in 2025
The $2,882 reported for 2025 was more than what 77% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,040 · 2020: $666 · 2021: $97.23 · 2022: $174 · 2023: $1,959 · 2024: $8,251 · 2025: $2,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,750 · Food and Beverage: $2,047 · Travel and Lodging: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,750.00 |
| Food and Beverage | $2,046.95 |
| Travel and Lodging | $1,294.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $15,371.24 | 2019-2025 | Anastoclip Gc 8cm (Medium), Hydro Lemaitre Valvulotome, Artegraft Vascular Graft |
| Smith+Nephew, INC. | $1,025.90 | 2019-2024 | Renasys Touch, Stravix Pl, Stravix |
| Kerecis Limited | $243.01 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| W. L. Gore & Associates, INC. | $141.26 | 2020 | |
| Baxter Healthcare | $124.74 | 2019 | |
| Bard Peripheral Vascular, INC. | $85.57 | 2019 | |
| Davol INC. | $31.05 | 2025 | Progel Applicator Spray Tips |
| Tela Bio, INC. | $30.60 | 2019 | |
| Mozarc Medical US LLC | $14.75 | 2025 | Argyle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kinter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.